Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 4469


Home  | About Us | Editors | Search | Ahead Of Print | Current Issue | Archives | Submit Article | Instructions | Subscribe | Contacts | Login 

    Article Cited by others


Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin?

Martins Noel B, Chaput Kimberly J, Stawicki Stanislaw P, Modi Ronak

Year : 2017| Volume: 7| Issue : 1 | Page no: 8-11

   This article has been cited by
1 Gastrointestinal Vascular Malformations in Patients with Turner’s Syndrome: A Systematic Review of Case Reports
Anna Kucharska, Pawel Józefczuk, Maciej Ksiazyk, Dominika Labochka, Aleksandra Banaszkiewicz
Hormone Research in Paediatrics. 2018; 90(1): 39
[Pubmed]  [Google Scholar] [DOI]
2 The benefit of new angiogenesis (bevacizumab and aflibercept) inhibitors for multiple angiomatosis therapy: a case report
Dagmar Brancíková,Lenka Ostrížková,Zdenek Adam,Tomáš Nebeský,Ludek Pour,Zdenek Král,Jirí Mayer
Vnitrní lékarství. 2017; 63(10): 672
[Pubmed]  [Google Scholar] [DOI]
3 Pharmacokinetic and pharmacodynamic evidence for developing an oral formulation of octreotide against gastric mucosal injury
Xi-nuo Li,Tai Rao,Yang-fan Xu,Kang-rui Hu,Zhang-pei Zhu,Hao-feng Li,Dian Kang,Yu-hao Shao,Bo-yu Shen,Xiao-xi Yin,Lin Xie,Guang-ji Wang,Yan Liang
Acta Pharmacologica Sinica. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article